Prime Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	107.66	55.07	201.12	198.55	36.98
Short-Term Investments	116.56	80.09	106.3	84.2	16.35
Cash & Cash Equivalents	224.22	135.16	307.42	282.75	53.33
Cash Growth	-14.75%	-56.03%	8.73%	430.20%	-
Other Current Assets	-6.57	7.82	-10.8	-12.17	0.07
Total Current Assets	217.65	142.98	296.62	270.58	53.4
Property, Plant & Equipment	79.45	36.6	48.55	15.68	0.6
Other Long-Term Assets	14.28	14.28	15.14	15.6	0.79
Total Long-Term Assets	93.73	50.88	63.7	31.28	1.38
Total Assets	311.38	193.85	360.31	301.86	54.78
Accounts Payable	10.08	19.54	4.33	1.44	0.25
Current Debt	6.75	9.28	11.69	7.34	0
Other Current Liabilities	7.61	27.61	10.69	49.21	19.19
Total Current Liabilities	24.44	56.42	26.71	57.98	19.44
Long-Term Debt	37.04	4.36	17.05	3.07	0
Other Long-Term Liabilities	6.13	0	0.28	1.24	1.87
Total Long-Term Liabilities	43.18	4.36	17.33	4.31	1.87
Total Liabilities	67.62	60.78	44.04	62.3	21.31
Total Debt	43.79	13.63	28.75	10.41	0
Debt Growth	68.67%	-52.57%	176.23%	-	-
Retained Earnings	-537.09	-491.33	-293.2	-171.38	-6.01
Comprehensive Income	-0.1	-0.02	-0.38	-0.03	0
Shareholders' Equity	243.77	133.07	316.27	-156.24	2.34
Net Cash / Debt	180.43	121.53	278.67	272.34	53.33
Net Cash / Debt Growth	-23.89%	-56.39%	2.33%	410.69%	-
Net Cash Per Share	1.73	1.34	8.22	20.99	20.20
Working Capital	193.21	86.55	269.9	212.6	33.96
Book Value Per Share	2.33	1.46	9.33	-12.04	0.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).